Exclusive: Cosmetic Surgeon Lists His Expansive Florida Mansion for $200 Million
South Florida Real Estate Boom: South Florida has seen a surge in $100 million home sales, attracting high-end listings in the ultrahigh market.
Record-Setting Mansion Listing: A nearly-completed mansion on Indian Creek is set to hit the market for $200 million, potentially becoming the most expensive sale in Miami-Dade County history.
Trade with 70% Backtested Accuracy
Analyst Views on AIRS
About AIRS
About the author


Market Performance: Hospital and medical practitioners' shares are down approximately 1.7% on Friday, with Agilon Health and AirSculpt Technologies leading the decline at 9% and 8.3%, respectively.
Sector Laggards: The construction sector, along with hospital and medical practitioners, is identified as a laggard in the market on Friday.
Video Coverage: A video segment highlights the performance of these sectors, focusing on the laggards in the market.
Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Oversold Stocks in Health Care: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Inotiv Inc Performance: Inotiv Inc reported strong contract awards and anticipates fourth-quarter revenue between $137.5 million and $138.5 million, despite its stock falling 38% recently, with an RSI of 26.7.
Airsculpt Technologies Update: Airsculpt Technologies faced disappointing third-quarter results and lowered its FY25 revenue outlook, leading to a 60% stock drop over the past month, with an RSI of 29.3.
Neuronetics Sales Guidance: Neuronetics cut its FY2025 sales guidance, resulting in a 40% decline in stock value over the past month, and it currently has an RSI of 23.9.
Appointment of New Chairman: AirSculpt Technologies has appointed Mike Doyle as the Non-Executive Chairman of its Board of Directors, bringing over 30 years of experience in the multi-center healthcare sector.
Leadership Experience: Doyle has a strong background in scaling healthcare organizations, having previously served as CEO of Surgery Partners and held leadership roles in various healthcare boards.
CEO's Statement: Yogi Jashnani, CEO of AirSculpt, expressed enthusiasm about Doyle's appointment, highlighting his experience in partnering with surgeons and developing new service lines.
About AirSculpt: AirSculpt offers a next-generation body contouring treatment that is minimally invasive, focusing on comfort and precision, with quick healing and minimal bruising.
South Florida Real Estate Boom: South Florida has seen a surge in $100 million home sales, attracting high-end listings in the ultrahigh market.
Record-Setting Mansion Listing: A nearly-completed mansion on Indian Creek is set to hit the market for $200 million, potentially becoming the most expensive sale in Miami-Dade County history.
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow up slightly by 0.06%, while the Nasdaq fell by 0.45% and the S&P 500 dropped by 0.04%.
Sector Movements: Energy shares increased by 1.2%, while communication services stocks saw a decline of 1.8%.
Consumer Sentiment Index: The University of Michigan's consumer sentiment index fell to 50.3 in November, down from 53.6 the previous month, missing market expectations.
Notable Stock Movements: Motorsport Games Inc. shares surged by 79% after positive sales results, while AirSculpt Technologies Inc. shares plummeted by 42% due to disappointing financial results.

Stock Performance: AirSculpt Technologies, Inc. (AIRS) experienced a significant drop of 42.76% in stock price, falling to $6.01 after disappointing third-quarter fiscal 2025 results.
Financial Results: The company reported a revenue of $35.0 million, a 17.8% decrease Year-over-Year, and an expanded net loss of $9.5 million compared to a loss of $6.0 million the previous year.
Revised Outlook: AirSculpt lowered its full-year 2025 revenue forecast to approximately $153 million from an earlier estimate of $160-$170 million, indicating weaker demand in the body-contouring market.
Market Reaction: Following the announcement, AIRS experienced heavy trading volume as investors reacted to the growth miss and reduced guidance, with the stock's 52-week range noted between $2.60 and $12.50.









